| 000 | 01794 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516013052.0 | ||
| 264 | 0 | _c20101217 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a0026-8984 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYerlikaya, Azmi | |
| 245 | 0 | 0 |
_aInvestigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells. _h[electronic resource] |
| 260 |
_bMolekuliarnaia biologiia _c |
||
| 300 |
_a859-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBenzhydryl Compounds _xpharmacology |
| 650 | 0 | 4 |
_aBoronic Acids _xpharmacology |
| 650 | 0 | 4 | _aBortezomib |
| 650 | 0 | 4 |
_aBreast Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aEukaryotic Initiation Factor-2 _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHSP70 Heat-Shock Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHeme Oxygenase-1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeupeptins _xpharmacology |
| 650 | 0 | 4 |
_aMelanoma _xmetabolism |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProteasome Endopeptidase Complex _xmetabolism |
| 650 | 0 | 4 | _aProteasome Inhibitors |
| 650 | 0 | 4 |
_aProtein Kinase C _xmetabolism |
| 650 | 0 | 4 |
_aProtoporphyrins _xpharmacology |
| 650 | 0 | 4 |
_aPyrazines _xpharmacology |
| 650 | 0 | 4 |
_aPyrrolidinones _xpharmacology |
| 650 | 0 | 4 |
_aeIF-2 Kinase _xmetabolism |
| 650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xmetabolism |
| 700 | 1 | _aDoKudur, Harun | |
| 773 | 0 |
_tMolekuliarnaia biologiia _gvol. 44 _gno. 5 _gp. 859-66 |
|
| 999 |
_c20386492 _d20386492 |
||